1: Kaemmerer D, Peter L, Lupp A, Schulz S, Sänger J, Prasad V, Kulkarni H, Haugvik SP, Hommann M, Baum RP. Molecular imaging with (68)Ga-SSTR ET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2011 May 31. [Epub ahead of print] PubMed PMID: 21626438.

2: Kolenc-Peitl P, Mansi R, Tamma M, Gmeiner-Stopar T, Sollner-Dolenc M, Waser B, Baum RP, Reubi JC, Maecke HR. Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor. J Med Chem. 2011 Apr 28;54(8):2602-9. Epub 2011 Apr 1. PubMed PMID: 21456601.

3: Rösch F, Baum RP. Generator-based PET radiopharmaceuticals for molecular imaging of tumours

In a perspective article published in Dalton Transactions Issue 16, 2011, Drs. Rösch and Baum discuss the use of generator based PET radiopharmaceuticals to assist in optimizing target radiotherapy in the article  "Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS." 

Dalton TransactionsThe perspective available for download here discusses the concept behind "Theranostics" and how radiopharmaceuticals play a pivotal role.

Quoted from the perspective: